Similar articles

• Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.

  Zittoun R, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P, Gattringer C, Petti MC, Solbu G, et al. Zittoun R, et al. Leukemia. 1992;6 Suppl 2:114-5. Leukemia. 1992. PMID: 1578909 Clinical Trial. No abstract available.
• Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.

  Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S. Zittoun R, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:56-8. Bone Marrow Transplant. 1990. PMID: 2202470 Clinical Trial. No abstract available.
• [Current situation and perspective for treatment of acute myelogenous leukemia in adults].

  Fukushima T, Ueda T. Fukushima T, et al. Gan To Kagaku Ryoho. 1998 Feb;25(3):295-302. Gan To Kagaku Ryoho. 1998. PMID: 9492819 Review. Japanese.
• Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

  Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Michel G, et al. Bone Marrow Transplant. 1996 Feb;17(2):191-6. Bone Marrow Transplant. 1996. PMID: 8640165 Clinical Trial.
• Autologous bone marrow transplantation in first remission AML--its relative value.

  de Gast GC, Zwaan FE, Hagenbeek T, Verdonck LF, Löwenberg B. de Gast GC, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:52-4. Bone Marrow Transplant. 1990. PMID: 2202468 Review. No abstract available.